MATTERHORN, ATOMIC, CHALLENGE, and More
July 22nd, 2025
Dr. Weinberg recaps key gastrointestinal cancer highlights from the 2025 ASCO Annual Meeting.…
Media Coverage
Discover how genetic testing can help identify these rare treatment targets
July 22nd, 2025
New Lombardi research shows that a safe and effective targeted therapy can slow tumor growth in patients with some types of pancreatic and lung cancers. …
EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer
July 22nd, 2025
Dr. Weinberg discusses promising early results from the EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer. …
Excersise and Colorectal Cancer
July 22nd, 2025
Dr. Weinberg discussing exercise post-adjuvant chemotherapy for colorectal cancer with Fox5 DC…
Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib:
July 22nd, 2025
Dr. Weinberg Discusses Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib…